Open access
Open access
Powered by Google Translator Translator

Archives

During the COVID-19 pandemic, female, primary care, and behavioral health physicians were most likely to be early adopters of virtual health care. Physicians born between 1928 and 1945 and in surgical specialties were less likely to be early adopters.

28 Jan, 2022 | 08:20h | UTC

Association of Physician Characteristics With Early Adoption of Virtual Health Care – JAMA Network Open

 


Development and use of a calculator to measure pediatric low-value care delivered in US children’s hospitals.

28 Jan, 2022 | 08:19h | UTC

Development and Use of a Calculator to Measure Pediatric Low-Value Care Delivered in US Children’s Hospitals – JAMA Network Open

Commentary: Pediatric Services With Limited Benefits Cost Millions – MedPage Today (free registration required)

 


Expert Review: Preeclampsia has two phenotypes which require different treatment strategies.

28 Jan, 2022 | 08:15h | UTC

Preeclampsia has two phenotypes which require different treatment strategies – American Journal of Obstetrics & Gynecology

 

Commentary on Twitter

 


Review: Juvenile idiopathic arthritis.

28 Jan, 2022 | 08:13h | UTC

Juvenile idiopathic arthritis – Nature Reviews Disease Primers (if the link is paywalled, try this one)

Infographic: Juvenile idiopathic arthritis (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Review: Perioperative management of polytrauma patients with severe traumatic brain injury undergoing emergency extracranial surgery.

28 Jan, 2022 | 08:14h | UTC

Perioperative Management of Polytrauma Patients with Severe Traumatic Brain Injury Undergoing Emergency Extracranial Surgery: A Narrative Review – Journal of Clinical Medicine

 


Perspective | Ultrahypofractionated radiotherapy for localized prostate cancer: how far can we go?

28 Jan, 2022 | 08:09h | UTC

Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go? – Clinical Oncology

 


Cohort Study: Bullous Pemphigoid is associated with a 5-fold higher risk of cardiovascular mortality.

28 Jan, 2022 | 08:11h | UTC

Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid – JAMA Dermatology (link to abstract – $ for full-text)

 


Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

28 Jan, 2022 | 08:05h | UTC

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease – European Heart Journal

 


Cardiac surgery-associated acute kidney injury: incidence, epidemiology, clinical outcomes, and economic impact.

28 Jan, 2022 | 08:04h | UTC

CSA-AKI: Incidence, Epidemiology, Clinical Outcomes, and Economic Impact – Journal of Clinical Medicine

 


Review: Management of acute traumatic spinal cord injury.

28 Jan, 2022 | 08:04h | UTC

Management of Acute Traumatic Spinal Cord Injury: A Review of the Literature – Frontiers of Surgery

 


M-A: Clinical and endoscopic characteristics associated with post-endoscopy upper gastrointestinal cancers.

28 Jan, 2022 | 08:08h | UTC

Clinical and Endoscopic Characteristics Associated with Post-Endoscopy Upper Gastrointestinal Cancers: a Systematic Review and Meta-analysis – Gastroenterology (link to abstract – $ for full-text)

 


Long-Term Results of RCT: Neoadjuvant chemoradiotherapy vs. upfront surgery for resectable and borderline resectable pancreatic cancer.

28 Jan, 2022 | 08:01h | UTC

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

 


RCT: In patients with chronic myeloid leukemia in chronic phase resistant/intolerant to ≥2 tyrosine kinase inhibitors, Asciminib resulted in better disease response compared to Bosutinib.

28 Jan, 2022 | 08:00h | UTC

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs – Blood

News Release: Asciminib Superior to Bosutinib in Chronic-Phase CML – ASH Clinical News

 


M-A: Surgical management of rib fractures after blunt trauma.

28 Jan, 2022 | 08:02h | UTC

Surgical management of rib fractures after blunt trauma: a systematic review and meta-analysis of randomised controlled trials – Annals of The Royal College of Surgeons of England

 


A nationwide, population-based case-control study showed dentist’s visits were not associated with increased risk of brain abscess.

28 Jan, 2022 | 07:58h | UTC

Dentist’s visits and risk of brain abscess: a nationwide, population-based case control study – Clinical Infectious Diseases (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.

27 Jan, 2022 | 10:03h | UTC

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant – New England Journal of Medicine

Commentary: Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds – University of Wisconsin-Madison

 

Commentary on Twitter

 


Opinion: Despite Omicron arriving, keeping schools open as safely as possible should be the goal.

27 Jan, 2022 | 09:58h | UTC

Despite Omicron arriving, keeping schools open as safely as possible should be the goal – The Conversation

 


Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.

27 Jan, 2022 | 10:00h | UTC

Lung Transplantation for Covid-19–Related Respiratory Failure in the United States – New England Journal of Medicine

Commentaries:

New data on COVID-19 lung transplants – Cedars-Sinai Medical Center

~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure – HealthDay

 


Omicron’s most crucial warning: A disease can move much faster than we can.

27 Jan, 2022 | 09:57h | UTC

Omicron’s most crucial warning: A disease can move much faster than we can – Vox

 


[Preprint] SARS-CoV-2 Omicron transmission in Danish households.

27 Jan, 2022 | 09:53h | UTC

SARS-CoV-2 Omicron VOC Transmission in Danish Households – medRxiv

News Release: Danish researchers investigate Omicron transmission in Danish households – Statens Serum Institut

 

Commentary on Twitter

 


AAP Report: Some alternative peripartum, neonatal practices carry disease risks.

27 Jan, 2022 | 09:41h | UTC

News Release: Some alternative peripartum, neonatal practices carry disease risks: AAP report – American Academy of Pediatrics

Report: Risks of Infectious Diseases in Newborns Exposed to Alternative Perinatal Practices – Pediatrics

Commentary: Risks Discussed for Alternative Peripartum, Neonatal Practices – HealthDay

 


Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study.

27 Jan, 2022 | 09:46h | UTC

Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study – Cancer

Editorial: The impact of the COVID‐19 pandemic in pediatric oncology units: A lesson of resilience and hope – Cancer

News Release: How has the COVID-19 pandemic impacted clinicians who care for children with cancer? – Wiley

 


Italian lab study finds Sputnik V beat Pfizer’s mRNA vaccine against Omicron – yielding higher antibody levels.

27 Jan, 2022 | 09:47h | UTC

Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels – Health Policy Watch

 


Perspective: From vaginal laser treatment to spa breaks – it’s the great menopause gold rush.

27 Jan, 2022 | 09:36h | UTC

From vaginal laser treatment to spa breaks – it’s the great menopause gold rush – The Guardian

 


Review | Immune-checkpoint inhibitors: long-term implications of toxicity.

27 Jan, 2022 | 09:39h | UTC

Immune-checkpoint inhibitors: long-term implications of toxicity – Nature Reviews Clinical Oncology (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.